Mohammad Masjedizadeh, Ph.D.

Mohammad Masjedizadeh, Ph.D., Executive Vice President, Chief Technical Officer

Dr. Masjedizadeh has served as Executive Vice President & Chief Technical Officer since June 2021 and has served as EVP/VP of Pharmaceutical Development from 2017-2021. Prior to joining Protagonist, he was VP and Senior Director of Technical Operations at Principia Biopharma (2012-2017), focusing on CMC development of Reversible Covalent BTK inhibitors. He worked at Roche Pharmaceuticals both in Palo Alto, CA and Nutley, NJ from 1991 to 2012 with increasing responsibilities leading to his promotion to Director of Drug Substance & Supply. Dr. Masjedizadeh received his Ph.D. in Organic Chemistry from University of California at Santa Barbara (UCSB) and conducted his post-doctoral work also at UCSB.